Exact Mass: 602.4424

Pipecuronium

C35H62N4O4+2 (602.4771)

D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C66886 - Nicotinic Antagonist D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists

Pipecuronium

C35H62N4O4 (602.4771)

Pipecuronium is only found in individuals that have used or taken this drug. It is a piperazinyl androstane derivative which is a non-depolarizing neuromuscular blocking agent.Nondepolarizing neuromuscular blocking agents inhibit neuromuscular transmission by competing with acetylcholine for the cholinergic receptors of the motor end plate, thereby reducing the response of the end plate to acetylcholine. This type of neuromuscular block is usually antagonized by anticholinesterase agents.

Karpoxanthin

C40H58O4 (602.4335)

Isolated from Capsicum annuum (red paprika pods). 5,6-Diepikarpoxanthin is found in many foods, some of which are orange bell pepper, red bell pepper, yellow bell pepper, and italian sweet red pepper. 5,6-Diepikarpoxanthin is found in fruits. 5,6-Diepikarpoxanthin is isolated from Capsicum annuum (red paprika pods).

Oryzanol A

C40H58O4 (602.4335)

Oryzanol A is found in cereals and cereal products. Oryzanol A is from rice bran oil (Oryza sativa

6-Epikarpoxanthin

C40H58O4 (602.4335)

6-Epikarpoxanthin is found in fruits. 6-Epikarpoxanthin is a constituent of Capsicum annuum (red paprika pods)

gamma-Oryzanol

C40H58O4 (602.4335)

DG(14:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C37H62O6 (602.4546)

DG(14:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/14:0/0:0)

C37H62O6 (602.4546)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(14:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C37H62O6 (602.4546)

DG(14:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/14:0)

C37H62O6 (602.4546)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(14:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C37H62O6 (602.4546)

DG(14:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/14:0/0:0)

C37H62O6 (602.4546)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(14:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C37H62O6 (602.4546)

DG(14:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/14:0)

C37H62O6 (602.4546)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(14:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C37H62O6 (602.4546)

DG(14:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/14:0/0:0)

C37H62O6 (602.4546)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(14:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

C37H62O6 (602.4546)

DG(14:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C37H62O6 (602.4546)

DG(i-14:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-14:0/0:0)

C37H62O6 (602.4546)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C37H62O6 (602.4546)

DG(i-14:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-14:0)

C37H62O6 (602.4546)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C37H62O6 (602.4546)

DG(i-14:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-14:0/0:0)

C37H62O6 (602.4546)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C37H62O6 (602.4546)

DG(i-14:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-14:0)

C37H62O6 (602.4546)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C37H62O6 (602.4546)

DG(i-14:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-14:0/0:0)

C37H62O6 (602.4546)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C37H62O6 (602.4546)

DG(i-14:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-14:0)

C37H62O6 (602.4546)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C37H62O6 (602.4546)

DG(i-14:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-14:0/0:0)

C37H62O6 (602.4546)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C37H62O6 (602.4546)

DG(i-14:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-14:0)

C37H62O6 (602.4546)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C37H62O6 (602.4546)

DG(i-14:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-14:0/0:0)

C37H62O6 (602.4546)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C37H62O6 (602.4546)

DG(i-14:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-14:0)

C37H62O6 (602.4546)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C37H62O6 (602.4546)

DG(i-14:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-14:0/0:0)

C37H62O6 (602.4546)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C37H62O6 (602.4546)

DG(i-14:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-14:0)

C37H62O6 (602.4546)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

5-Hydroxycapsanthin-5,6-epoxide

C39H54O5 (602.3971)

5-hydroxycapsanthin-5,6-epoxide is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 5-hydroxycapsanthin-5,6-epoxide can be found in a number of food items such as red bell pepper, orange bell pepper, pepper (c. annuum), and green bell pepper, which makes 5-hydroxycapsanthin-5,6-epoxide a potential biomarker for the consumption of these food products.

Oryzanol

C40H58O4 (602.4335)

Oryzanol belongs to cycloartanols and derivatives class of compounds. Those are steroids containing a cycloartanol moiety. Oryzanol is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Oryzanol can be found in barley, which makes oryzanol a potential biomarker for the consumption of this food product. Rice bran oil is the oil extracted from the hard outer brown layer of rice after chaff (rice husk). It is known for its high smoke point of 232 ¬∞C (450 ¬∞F) and mild flavor, making it suitable for high-temperature cooking methods such as stir frying and deep frying. It is popular as a cooking oil in several Asian countries, including Bangladesh, Japan, India and China . Oryzanol belongs to cycloartanols and derivatives class of compounds. Those are steroids containing a cycloartanol moiety. Oryzanol is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Oryzanol can be found in barley, which makes oryzanol a potential biomarker for the consumption of this food product. Rice bran oil is the oil extracted from the hard outer brown layer of rice after chaff (rice husk). It is known for its high smoke point of 232 °C (450 °F) and mild flavor, making it suitable for high-temperature cooking methods such as stir frying and deep frying. It is popular as a cooking oil in several Asian countries, including Bangladesh, Japan, India and China . γ-Oryzanol is a potent DNA methyltransferases (DNMTs) inhibitor in the striatum of mice. γ-Oryzanol significantly inhibits the activities of DNMT1 (IC50=3.2 μM), DNMT3a (IC50=22.3 μM).

Calcium oleate

C36H66CaO4 (602.4587)

It is used as a food additive .

Ursolic acid (cis-3-O-hydroxycinnamoyl-)

C39H54O5 (602.3971)

Ursolic acid (trans-3-O-hydroxycinnamoyl-)

C39H54O5 (602.3971)

3alpha-E-Feruloyltaraxerol

C40H58O4 (602.4335)

Lup-20(29)en-28-al-3beta-yl caffeate

C39H54O5 (602.3971)

tenacibactin D

C28H54N6O8 (602.4003)

1,1,2,2,7,8-Hexahydro-1-hydroxy-1-methoxy-psi,psi-caroten-4-one

C41H62O3 (602.4699)

Argentinic acid A

C36H58O7 (602.4182)

Karpoxanthin

C40H58O4 (602.4335)

5,6-Dihydroxylutein

C40H58O4 (602.4335)

3-[(beta-D-glucopyranosyl)oxy]-beta-amyrin

C36H58O7 (602.4182)

3beta-E-Feruloyltaraxerol

C40H58O4 (602.4335)

3beta-(E)-feruoloyllupeol|3beta-E-feruloyllupeol

C40H58O4 (602.4335)

C36H58O7

C36H58O7 (602.4182)

jatrocurin

C40H58O4 (602.4335)

Mimulaxanthin

C40H58O4 (602.4335)

3beta-O-(E)-(4-methoxy)cinnamoyl-15alpha-hydroxy-beta-amyrin

C40H58O4 (602.4335)

C34H66O8

C34H66O8 (602.4757)

(trans-3-O-p-hydroxycinnamoyl)ursolic acid|3-(p-coumaroyl)ursolic acid|3-O-(E)-p-coumaroylursolic acid|Chuanxiongterpene|trans-3-O-p-hydroxycinnamoylursolic acid

C39H54O5 (602.3971)

C40H58O4

C40H58O4 (602.4335)

3beta-hydroxy-21beta-E-cinnamoyloxyolean-12-en-28-oic acid

C39H54O5 (602.3971)

24-methylene-lanosta-8-(9)-ene 3-O-beta-D-glucopyranoside|marianoside B

C37H62O6 (602.4546)

Saponosid C

C36H58O7 (602.4182)

Cycloswietenol-3-O-beta-D-glucoside

C37H62O6 (602.4546)

3-O-acetyl-12beta-acetoxy-25-O-ethylcleocarpanol

C36H58O7 (602.4182)

3alpha-O-trans-coumaroylbetulinic acid

C39H54O5 (602.3971)

3-O-p-Coumaroyloleanolic acid

C39H54O5 (602.3971)

lanost-5,24-dien-3beta-D-glucuronopyranoside

C36H58O7 (602.4182)

Fucoxanthinol

C39H54O5 (602.3971)

4,12,20,24,26,28-Hexahydroxy-2,10,18-tritriacontanetrione

C33H62O9 (602.4394)

beta-amyrin ferulate

C40H58O4 (602.4335)

27-Ketone,1-O-alpha-D-Glucopyranoside-(3R)-1,3,27-Octacosanetriol

C34H66O8 (602.4757)

abiestetrane A

C40H58O4 (602.4335)

abiestetrane B

C40H58O4 (602.4335)

ingenol 6,7-epoxy-3- tetradecanoate

C36H58O7 (602.4182)

7alpha-oxomultiflor-8-ene-3alpha,29-diol 3-acetate-29-benzoate

C39H54O5 (602.3971)

3-O-beta-L-fucose-13,28-epoxy-3beta,23-dihydroxy-11-oleanane|mimengoside I

C36H58O7 (602.4182)

aleuritolic acid 3-p-hydroxycinnamate

C39H54O5 (602.3971)

olean-11-ene-28-oxo-3beta-yl trans-caffeate

C39H54O5 (602.3971)

Vaucheriaxanthin

C39H54O5 (602.3971)

(3beta,16beta)-16-hydroxylup-20(29)-en-3-yl (E)-3-(4-hydroxyphenyl)prop-2-enoate

C40H58O4 (602.4335)

olean-12-en-28-al-3beta-yl caffeate|Olean-28-al-3??-yl-caffeate

C39H54O5 (602.3971)

3beta-O-(E)-3,5-dihydroxycinnamoyl-11-oxo-olean-12-ene

C39H54O5 (602.3971)

olean-3-O-alpha-L-rhamnopyranosyl-Delta12-en-28-oic acid

C36H58O7 (602.4182)

22beta-hydroxyolean-11,13(18)-dien-3beta-yl-beta-D-glucopyranoside

C36H58O7 (602.4182)

1-[3,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy]-27-hydroxyoctacosane-3-one

C34H66O8 (602.4757)

Tohogeninoltriacetat

C36H58O7 (602.4182)

NSC281270

C36H58O7 (602.4182)

3-beta-caffeoyl-12-oleanen-28-oic acid

C39H54O5 (602.3971)

argentinic acid B methyl ester

C36H58O7 (602.4182)

3alpha-(E)-coumaroyloxyolean-12-en-30-oic acid

C39H54O5 (602.3971)

alpha-L-rhamnopyranosyl-3beta-hydroxy-lup-20(29)-en-28-oic acid|betulinic acid 3-O-alpha-L-rhamnopyranoside|lup-20(29)-en-28-oic-3-O-alpha-L-rhamnopyranoside|RhaBetA|??-L-Rhamnopyranosyl-3??-hydroxy-lup-20(29)-en-28-oic acid

C36H58O7 (602.4182)

2alpha-hydroxy-3beta-{[(2Z)-3-phenyl-1-oxo-2-propenyl]oxy}olean-12-en-28-oic acid|3beta-cis-cinnamoyloxy-2alpha-hydroxyolean-12-en-28-oic acid

C39H54O5 (602.3971)

3??-[(m-Methoxybenzoyl)oxyl]urs-12-en-28-oic acid

C39H54O5 (602.3971)

2alpha-hydroxy-3beta-{[(2E)-3-phenyl-1-oxo-2-propenyl]oxy}urs-12-en-28-oic acid|3beta-trans-cinnamoyloxy-2alpha-hydroxyurs-12-en-28-oic acid

C39H54O5 (602.3971)

C39H54O5

C39H54O5 (602.3971)

luteoxanthin

C40H58O4 (602.4335)

Oliver

C40H58O4 (602.4335)

Gamma-Oryzanol (TN) is a triterpenoid. gamma-Oryzanol is a natural product found in Krameria bicolor, Krameria grayi, and other organisms with data available. C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent Cycloartenyl ferulate (Cycloartenol ferulate) is one of the typical triterpene alcohols and possesses several biological activities including anti-oxidative activity, antiallergic activity, anti-inflammatory and anticancer activities[1]. γ-Oryzanol is a potent DNA methyltransferases (DNMTs) inhibitor in the striatum of mice. γ-Oryzanol significantly inhibits the activities of DNMT1 (IC50=3.2 μM), DNMT3a (IC50=22.3 μM).

Dereplicator Identification - (3s,5R,3S,5R)-5,5-Dihydro-3,5,3,5-t

C40H58O4 (602.4335)

PE-Cer(d14:2(4E,6E)/16:0)

C32H63N2O6P (602.4424)

1-(O-alpha-D-glucopyranosyl)-3-keto-(1,27R)-octacosanediol

C34H66O8 (602.4757)

1-(O-alpha-D-mannopyranosyl)-3-keto-(1,27R)-octacosanediol

C34H66O8 (602.4757)

PA(12:0/17:2(9Z,12Z))

C32H59O8P (602.3947)

PA(14:1(9Z)/15:1(9Z))

C32H59O8P (602.3947)

PA(15:1(9Z)/14:1(9Z))

C32H59O8P (602.3947)

PA(17:2(9Z,12Z)/12:0)

C32H59O8P (602.3947)

PA(P-16:0/14:1(9Z))

C33H63O7P (602.4311)

6-Epikarpoxanthin

C40H58O4 (602.4335)

Oryzanol A

C40H58O4 (602.4335)

D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D009676 - Noxae > D000963 - Antimetabolites From rice bran oil (Oryza sativa). Oryzanol A is found in cereals and cereal products, rice, and fats and oils. γ-Oryzanol is a potent DNA methyltransferases (DNMTs) inhibitor in the striatum of mice. γ-Oryzanol significantly inhibits the activities of DNMT1 (IC50=3.2 μM), DNMT3a (IC50=22.3 μM).

PA 29:2

C32H59O8P (602.3947)

PA O-30:2

C33H63O7P (602.4311)

CerPE 30:2;O2

C32H63N2O6P (602.4424)

R.g.Keto-VII

C41H62O3 (602.4699)

5,6-Diepikarpoxanthin

C40H58O4 (602.4335)

Kuesteriaxanthin

C40H58O4 (602.4335)

nonoxynol-9

C32H58O10 (602.403)

Orizanol

C40H58O4 (602.4335)

3-(p-Coumaroyl)ursolic acid

C39H54O5 (602.3971)

cis-3-O-p-hydroxycinnamoyl ursolic acid

C39H54O5 (602.3971)

9-Octadecenoic acid, calcium salt (1:1), (9E)-

C36H66CaO4 (602.4587)

γ-Oryzanol

C40H58O4 (602.4335)

C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent Cycloartenyl ferulate (Cycloartenol ferulate) is one of the typical triterpene alcohols and possesses several biological activities including anti-oxidative activity, antiallergic activity, anti-inflammatory and anticancer activities[1]. γ-Oryzanol is a potent DNA methyltransferases (DNMTs) inhibitor in the striatum of mice. γ-Oryzanol significantly inhibits the activities of DNMT1 (IC50=3.2 μM), DNMT3a (IC50=22.3 μM).

(27R)-27-hydroxy-3-oxooctacosyl alpha-D-glucopyranoside

C34H66O8 (602.4757)

7,8-Dihydroneoxanthin

C40H58O4 (602.4335)

(E,9R,11R)-9,11-dihydroxy-29-(4-hydroxyphenyl)-2,4-dimethyl-3-oxononacos-4-enoic acid

C37H62O6 (602.4546)

5-Hydroxycapsanthin-5,6-epoxide

C39H54O5 (602.3971)

DG(14:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C37H62O6 (602.4546)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/14:0/0:0)

C37H62O6 (602.4546)

DG(14:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C37H62O6 (602.4546)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/14:0)

C37H62O6 (602.4546)

DG(i-14:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C37H62O6 (602.4546)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-14:0/0:0)

C37H62O6 (602.4546)

DG(i-14:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C37H62O6 (602.4546)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-14:0)

C37H62O6 (602.4546)

DG(14:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C37H62O6 (602.4546)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/14:0/0:0)

C37H62O6 (602.4546)

DG(14:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C37H62O6 (602.4546)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/14:0)

C37H62O6 (602.4546)

DG(14:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C37H62O6 (602.4546)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/14:0/0:0)

C37H62O6 (602.4546)

DG(i-14:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C37H62O6 (602.4546)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-14:0/0:0)

C37H62O6 (602.4546)

DG(i-14:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C37H62O6 (602.4546)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-14:0)

C37H62O6 (602.4546)

DG(i-14:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C37H62O6 (602.4546)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-14:0/0:0)

C37H62O6 (602.4546)

DG(i-14:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C37H62O6 (602.4546)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-14:0)

C37H62O6 (602.4546)

DG(i-14:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C37H62O6 (602.4546)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-14:0/0:0)

C37H62O6 (602.4546)

DG(i-14:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C37H62O6 (602.4546)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-14:0)

C37H62O6 (602.4546)

DG(i-14:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C37H62O6 (602.4546)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-14:0/0:0)

C37H62O6 (602.4546)

DG(i-14:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C37H62O6 (602.4546)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-14:0)

C37H62O6 (602.4546)

DG(i-14:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C37H62O6 (602.4546)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-14:0/0:0)

C37H62O6 (602.4546)

DG(i-14:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C37H62O6 (602.4546)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-14:0)

C37H62O6 (602.4546)

DG(14:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

C37H62O6 (602.4546)

Marianoside B

C37H62O6 (602.4546)

A triterpene glycoside that is lanost-8-ene substituted by a methylidene group at position 24 and a beta-D-glucopyranosyloxy group at position 3. Isolated from the whole plant of Silybum marianum, it exhibits inhibitory activity against chymotrypsin.

Cycloartenyl ferulate

C40H58O4 (602.4335)

Cycloartenyl ferulate (Cycloartenol ferulate) is one of the typical triterpene alcohols and possesses several biological activities including anti-oxidative activity, antiallergic activity, anti-inflammatory and anticancer activities[1].

(27R)-27-hydroxy-3-oxooctacosyl alpha-D-mannopyranoside

C34H66O8 (602.4757)

N-[(3R,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide

C33H54N4O6 (602.4043)

N-[[(3S,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylcyclohexanecarboxamide

C33H54N4O6 (602.4043)

N-[[(3R,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylcyclohexanecarboxamide

C33H54N4O6 (602.4043)

N-[[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylcyclohexanecarboxamide

C33H54N4O6 (602.4043)

N-[[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylcyclohexanecarboxamide

C33H54N4O6 (602.4043)

N-[[(3R,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylcyclohexanecarboxamide

C33H54N4O6 (602.4043)

N-[(3S,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide

C33H54N4O6 (602.4043)

N-[(3R,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide

C33H54N4O6 (602.4043)

N-[(3R,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide

C33H54N4O6 (602.4043)

N-[[(3S,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylcyclohexanecarboxamide

C33H54N4O6 (602.4043)

N-[(3S,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide

C33H54N4O6 (602.4043)

N-[(3S,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide

C33H54N4O6 (602.4043)

N-[(3R,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide

C33H54N4O6 (602.4043)

N-[(3S,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide

C33H54N4O6 (602.4043)

N-[[(3R,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylcyclohexanecarboxamide

C33H54N4O6 (602.4043)

N-[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide

C33H54N4O6 (602.4043)

N-[(3R,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide

C33H54N4O6 (602.4043)

N-[[(3R,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylcyclohexanecarboxamide

C33H54N4O6 (602.4043)

N-[[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylcyclohexanecarboxamide

C33H54N4O6 (602.4043)

N-[[(3R,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylcyclohexanecarboxamide

C33H54N4O6 (602.4043)

N-[(3S,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide

C33H54N4O6 (602.4043)

N-[[(3S,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylcyclohexanecarboxamide

C33H54N4O6 (602.4043)

N-[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide

C33H54N4O6 (602.4043)

N-[[(3R,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylcyclohexanecarboxamide

C33H54N4O6 (602.4043)

N-[[(3S,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylcyclohexanecarboxamide

C33H54N4O6 (602.4043)

N-[[(3S,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylcyclohexanecarboxamide

C33H54N4O6 (602.4043)

N-[(3S,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide

C33H54N4O6 (602.4043)

N-[[(3S,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylcyclohexanecarboxamide

C33H54N4O6 (602.4043)

N-[[(3S,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylcyclohexanecarboxamide

C33H54N4O6 (602.4043)

N-[(3S,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide

C33H54N4O6 (602.4043)

N-[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]cyclohexanecarboxamide

C33H54N4O6 (602.4043)

Dereplicator Identification-(3s,5R,3S,5R)-5,5-Dihydro-3,5,3,5-t

C40H58O4 (602.4335)

NAOrn 18:4/13:0

C36H62N2O5 (602.4658)

NAOrn 16:3/15:1

C36H62N2O5 (602.4658)

NAOrn 15:1/16:3

C36H62N2O5 (602.4658)

NAOrn 18:3/13:1

C36H62N2O5 (602.4658)

NAOrn 16:4/15:0

C36H62N2O5 (602.4658)

NAOrn 11:0/20:4

C36H62N2O5 (602.4658)

NAOrn 13:1/18:3

C36H62N2O5 (602.4658)

NAOrn 20:4/11:0

C36H62N2O5 (602.4658)

2,3-dihydroxypropyl [3-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoxy]-2-hydroxypropyl] hydrogen phosphate

C32H59O8P (602.3947)

Mgdg O-15:1_9:0

C33H62O9 (602.4394)

Mgdg O-16:1_8:0

C33H62O9 (602.4394)

Mgdg O-19:1_5:0

C33H62O9 (602.4394)

Mgdg O-22:1_2:0

C33H62O9 (602.4394)

Mgdg O-21:1_3:0

C33H62O9 (602.4394)

Mgdg O-17:1_7:0

C33H62O9 (602.4394)

Mgdg O-9:0_15:1

C33H62O9 (602.4394)

Mgdg O-18:1_6:0

C33H62O9 (602.4394)

Mgdg O-20:1_4:0

C33H62O9 (602.4394)

Mgdg O-8:0_16:1

C33H62O9 (602.4394)

Mgdg O-11:0_13:1

C33H62O9 (602.4394)

Mgdg O-10:0_14:1

C33H62O9 (602.4394)

Mgdg O-14:1_10:0

C33H62O9 (602.4394)

Mgdg O-13:1_11:0

C33H62O9 (602.4394)

PE-Cer 12:1;2O/18:1

C32H63N2O6P (602.4424)

PE-Cer 16:2;2O/14:0

C32H63N2O6P (602.4424)

PE-Cer 14:0;2O/16:2

C32H63N2O6P (602.4424)

PE-Cer 13:1;2O/17:1

C32H63N2O6P (602.4424)

PE-Cer 12:0;2O/18:2

C32H63N2O6P (602.4424)

PE-Cer 13:0;2O/17:2

C32H63N2O6P (602.4424)

PE-Cer 14:1;2O/16:1

C32H63N2O6P (602.4424)

PE-Cer 17:2;2O/13:0

C32H63N2O6P (602.4424)

PE-Cer 14:2;2O/16:0

C32H63N2O6P (602.4424)

PE-Cer 12:2;2O/18:0

C32H63N2O6P (602.4424)

PE-Cer 17:1;2O/13:1

C32H63N2O6P (602.4424)

PE-Cer 13:2;2O/17:0

C32H63N2O6P (602.4424)

PE-Cer 16:1;2O/14:1

C32H63N2O6P (602.4424)

PE-Cer 15:2;2O/15:0

C32H63N2O6P (602.4424)

PE-Cer 18:2;2O/12:0

C32H63N2O6P (602.4424)

PE-Cer 15:1;2O/15:1

C32H63N2O6P (602.4424)

PE-Cer 17:2;2O/12:1;O

C31H59N2O7P (602.406)

PE-Cer 15:2;2O/14:1;O

C31H59N2O7P (602.406)

PE-Cer 13:1;2O/16:2;O

C31H59N2O7P (602.406)

PE-Cer 17:3;2O/12:0;O

C31H59N2O7P (602.406)

PE-Cer 14:2;2O/15:1;O

C31H59N2O7P (602.406)

PE-Cer 14:3;2O/15:0;O

C31H59N2O7P (602.406)

PE-Cer 16:3;2O/13:0;O

C31H59N2O7P (602.406)

PE-Cer 15:3;2O/14:0;O

C31H59N2O7P (602.406)

PE-Cer 16:2;2O/13:1;O

C31H59N2O7P (602.406)

PE-Cer 13:2;2O/16:1;O

C31H59N2O7P (602.406)

[(E)-3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]oct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H63N2O6P (602.4424)

[(4E,8E)-2-(heptanoylamino)-3-hydroxyicosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H63N2O6P (602.4424)

[(4E,8E)-3-hydroxy-2-(octanoylamino)nonadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H63N2O6P (602.4424)

[(4E,8E)-3-hydroxy-2-(pentanoylamino)docosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H63N2O6P (602.4424)

[(4E,8E)-2-(butanoylamino)-3-hydroxytricosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H63N2O6P (602.4424)

[(4E,8E)-3-hydroxy-2-(propanoylamino)tetracosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H63N2O6P (602.4424)

[3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]nonyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H63N2O6P (602.4424)

[(4E,8E)-3-hydroxy-2-(nonanoylamino)octadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H63N2O6P (602.4424)

[(4E,8E)-2-(hexanoylamino)-3-hydroxyhenicosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H63N2O6P (602.4424)

[(4E,8E)-2-acetamido-3-hydroxypentacosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H63N2O6P (602.4424)

[(E)-3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]non-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H63N2O6P (602.4424)

[(4E,8E)-2-(decanoylamino)-3-hydroxyheptadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H63N2O6P (602.4424)

[(4E,8E)-3-hydroxy-2-(pentadecanoylamino)dodeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H63N2O6P (602.4424)

[(E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]tridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H63N2O6P (602.4424)

[(E)-2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxydec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H63N2O6P (602.4424)

[(4E,8E)-3-hydroxy-2-(undecanoylamino)hexadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H63N2O6P (602.4424)

[(E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]dodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H63N2O6P (602.4424)

[(E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]tetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H63N2O6P (602.4424)

[(4E,8E)-3-hydroxy-2-(tetradecanoylamino)trideca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H63N2O6P (602.4424)

[2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxydecyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H63N2O6P (602.4424)

[2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxyundecyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H63N2O6P (602.4424)

[(E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxyundec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H63N2O6P (602.4424)

2,3-di(octanoyloxy)propyl (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C37H62O6 (602.4546)

2,3-di(nonanoyloxy)propyl (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C37H62O6 (602.4546)

(2-decanoyloxy-3-octanoyloxypropyl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C37H62O6 (602.4546)

PEtOH 27:2

C32H59O8P (602.3947)

Fahfa 40:10

C40H58O4 (602.4335)

PMeOH 14:1_14:1

C32H59O8P (602.3947)

PMeOH 13:1_15:1

C32H59O8P (602.3947)

PMeOH 12:0_16:2

C32H59O8P (602.3947)

[1-nonanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-tetradec-9-enoate

C32H58O10 (602.403)

[1-heptanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-hexadec-9-enoate

C32H58O10 (602.403)

[1-pentanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-octadec-9-enoate

C32H58O10 (602.403)

[1-octanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-pentadec-9-enoate

C32H58O10 (602.403)

[1-acetyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-henicos-11-enoate

C32H58O10 (602.403)

[1-propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-icos-11-enoate

C32H58O10 (602.403)

[1-butanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-nonadec-9-enoate

C32H58O10 (602.403)

[1-hexanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-heptadec-9-enoate

C32H58O10 (602.403)

[1-decanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-tridec-9-enoate

C32H58O10 (602.403)

[3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]octyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H63N2O6P (602.4424)

[(4E,8E)-3-hydroxy-2-(tridecanoylamino)tetradeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H63N2O6P (602.4424)

[(4E,8E)-2-(dodecanoylamino)-3-hydroxypentadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H63N2O6P (602.4424)

[(E)-3-hydroxy-2-[[(Z)-tridec-8-enoyl]amino]tetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H63N2O6P (602.4424)

[(E)-2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxypentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H63N2O6P (602.4424)

[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-hydroxypropan-2-yl] (7E,9E,11E,13E,15E,17E)-icosa-7,9,11,13,15,17-hexaenoate

C39H54O5 (602.3971)

[(2S,3R,4E,8E)-3-hydroxy-2-(tridecanoylamino)tetradeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H63N2O6P (602.4424)

[(2S,3R,4E,8E)-2-(decanoylamino)-3-hydroxyheptadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H63N2O6P (602.4424)

[(2S,3R,4E,6E)-3-hydroxy-2-(tridecanoylamino)tetradeca-4,6-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H63N2O6P (602.4424)

[(2S,3R,4E,6E)-2-(dodecanoylamino)-3-hydroxypentadeca-4,6-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H63N2O6P (602.4424)

[(2S,3R,4E,8E)-2-(dodecanoylamino)-3-hydroxypentadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H63N2O6P (602.4424)

[1-carboxy-3-[3-[(8E,11E,14E,17E,20E,23E)-hexacosa-8,11,14,17,20,23-hexaenoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium

C36H60NO6+ (602.442)

2-[[2-hexanoyloxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H61NO7P+ (602.4185)

2-[[2-butanoyloxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H61NO7P+ (602.4185)

[1-carboxy-3-[2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-propanoyloxypropoxy]propyl]-trimethylazanium

C35H56NO7+ (602.4057)

2-[[2-acetyloxy-3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H61NO7P+ (602.4185)

2-[Carboxy-(3-nonanoyloxy-2-tetradecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

C33H64NO8+ (602.4632)

2-[Carboxy-(2-dodecanoyloxy-3-undecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

C33H64NO8+ (602.4632)

2-[Carboxy-(3-decanoyloxy-2-tridecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

C33H64NO8+ (602.4632)

2-[hydroxy-[2-hydroxy-3-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C32H61NO7P+ (602.4185)

2-[Carboxy-(3-octanoyloxy-2-pentadecanoyloxypropoxy)methoxy]ethyl-trimethylazanium

C33H64NO8+ (602.4632)

2-[[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-octoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H61NO7P+ (602.4185)

2-[[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-2-octanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H61NO7P+ (602.4185)

3-O-feruloylcycloartenol

C40H58O4 (602.4335)

A pentacyclic triterpenoid that is the cinnamate ester of cycloartenol. It has been isolated from the mycelia of Cordyceps sinensis.

1-(alpha-D-mannosyl)-3-keto-(1,27R)-octacosanediol

C34H66O8 (602.4757)

An alpha-D-glucoside that is (27R)-1,27-dihydroxyoctacosan-3-one on which the hydroxyl hydrogen at position 1 has been replaced by an alpha-D-mannosyl residue.

1-(alpha-D-glucosyl)-3-keto-(1,27R)-octacosanediol

C34H66O8 (602.4757)

An alpha-D-glucoside that is (27R)-1,27-dihydroxyoctacosan-3-one on which the hydroxyl hydrogen at position 1 has been replaced by an alpha-D-glucosyl residue.

TG(34:4)

C37H62O6 (602.4546)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

BisMePA(28:2)

C33H63O7P (602.4311)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

NA-Orn 31:4

C36H62N2O5 (602.4658)

FAHFA 14:3/O-26:7

C40H58O4 (602.4335)

FAHFA 14:4/O-26:6

C40H58O4 (602.4335)

FAHFA 15:3/O-25:7

C40H58O4 (602.4335)

FAHFA 15:4/O-25:6

C40H58O4 (602.4335)

FAHFA 15:5/O-25:5

C40H58O4 (602.4335)

FAHFA 16:3/O-24:7

C40H58O4 (602.4335)

FAHFA 16:4/O-24:6

C40H58O4 (602.4335)

FAHFA 16:5/O-24:5

C40H58O4 (602.4335)

FAHFA 17:3/O-23:7

C40H58O4 (602.4335)

FAHFA 17:4/O-23:6

C40H58O4 (602.4335)

FAHFA 17:5/O-23:5

C40H58O4 (602.4335)

FAHFA 18:3/O-22:7

C40H58O4 (602.4335)

FAHFA 18:4/O-22:6

C40H58O4 (602.4335)

FAHFA 18:5/O-22:5

C40H58O4 (602.4335)

FAHFA 18:6/O-22:4

C40H58O4 (602.4335)

FAHFA 19:3/O-21:7

C40H58O4 (602.4335)

FAHFA 19:4/O-21:6

C40H58O4 (602.4335)

FAHFA 19:5/O-21:5

C40H58O4 (602.4335)

FAHFA 19:6/O-21:4

C40H58O4 (602.4335)

FAHFA 20:4/O-20:6

C40H58O4 (602.4335)

FAHFA 20:5/O-20:5

C40H58O4 (602.4335)

FAHFA 20:6/O-20:4

C40H58O4 (602.4335)

FAHFA 21:4/O-19:6

C40H58O4 (602.4335)

FAHFA 21:5/O-19:5

C40H58O4 (602.4335)

FAHFA 21:6/O-19:4

C40H58O4 (602.4335)

FAHFA 21:7/O-19:3

C40H58O4 (602.4335)

FAHFA 22:4/O-18:6

C40H58O4 (602.4335)

FAHFA 22:5/O-18:5

C40H58O4 (602.4335)

FAHFA 22:6/O-18:4

C40H58O4 (602.4335)

FAHFA 22:7/O-18:3

C40H58O4 (602.4335)

FAHFA 23:5/O-17:5

C40H58O4 (602.4335)

FAHFA 23:6/O-17:4

C40H58O4 (602.4335)

FAHFA 23:7/O-17:3

C40H58O4 (602.4335)

FAHFA 24:5/O-16:5

C40H58O4 (602.4335)

FAHFA 24:6/O-16:4

C40H58O4 (602.4335)

FAHFA 24:7/O-16:3

C40H58O4 (602.4335)

FAHFA 25:5/O-15:5

C40H58O4 (602.4335)

FAHFA 25:6/O-15:4

C40H58O4 (602.4335)

FAHFA 25:7/O-15:3

C40H58O4 (602.4335)

FAHFA 26:6/O-14:4

C40H58O4 (602.4335)

FAHFA 26:7/O-14:3

C40H58O4 (602.4335)

FAHFA 40:10;O

C40H58O4 (602.4335)

MGDG O-23:2;O

C32H58O10 (602.403)

MGDG O-24:1

C33H62O9 (602.4394)

MGMG 24:1

C33H62O9 (602.4394)

MGGA 23:1

C32H58O10 (602.403)

PA O-14:1/16:1

C33H63O7P (602.4311)

PA O-16:1/14:1

C33H63O7P (602.4311)

PA O-16:2/14:0

C33H63O7P (602.4311)

PA O-18:2/12:0

C33H63O7P (602.4311)

PA O-20:2/10:0

C33H63O7P (602.4311)

PA P-14:0/16:1

C33H63O7P (602.4311)

PA P-14:0/16:1 or PA O-14:1/16:1

C33H63O7P (602.4311)

PA P-16:0/14:1

C33H63O7P (602.4311)

PA P-16:0/14:1 or PA O-16:1/14:1

C33H63O7P (602.4311)

PA P-16:1/14:0

C33H63O7P (602.4311)

PA P-16:1/14:0 or PA O-16:2/14:0

C33H63O7P (602.4311)

PA P-18:1/12:0

C33H63O7P (602.4311)

PA P-18:1/12:0 or PA O-18:2/12:0

C33H63O7P (602.4311)

PA P-20:1/10:0

C33H63O7P (602.4311)

PA P-20:1/10:0 or PA O-20:2/10:0

C33H63O7P (602.4311)

PA P-30:1

C33H63O7P (602.4311)

PA P-30:1 or PA O-30:2

C33H63O7P (602.4311)

LPEth 28:2

C33H63O7P (602.4311)

LPM 29:2

C33H63O7P (602.4311)

CerPE 12:0;O2/18:2

C32H63N2O6P (602.4424)

CerPE 14:1;O2/16:1

C32H63N2O6P (602.4424)

CerPE 14:2;O2/16:0

C32H63N2O6P (602.4424)

CerPE 15:1;O2/15:1

C32H63N2O6P (602.4424)

CerPE 15:2;O2/15:0

C32H63N2O6P (602.4424)

CerPE 16:1;O2/14:1

C32H63N2O6P (602.4424)

CerPE 16:2;O2/14:0

C32H63N2O6P (602.4424)

CerPE 17:2;O2/13:0

C32H63N2O6P (602.4424)

CerPE 18:2;O2/12:0

C32H63N2O6P (602.4424)

CerPE 19:2;O2/11:0

C32H63N2O6P (602.4424)

CerPE 20:2;O2/10:0

C32H63N2O6P (602.4424)

SM 14:2;O2/13:0

C32H63N2O6P (602.4424)

SM 15:2;O2/12:0

C32H63N2O6P (602.4424)

SM 16:2;O2/11:0

C32H63N2O6P (602.4424)

SM 17:2;O2/10:0

C32H63N2O6P (602.4424)

SM 27:2;O2

C32H63N2O6P (602.4424)

CAE 13:1

C37H62O6 (602.4546)

(27r)-27-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octacosan-3-one

C34H66O8 (602.4757)

(4s,6s,8s,10s,12s,14s,16s,18s,19e)-4,6,8,10,12,14,16,18-octamethoxy-19-methylpentacosa-1,19-diene

C34H66O8 (602.4757)

(3r,4ar,6bs,8as,11r,12ar,12bs,14bs)-11-[(acetyloxy)methyl]-4,4,6b,8a,11,12b,14b-heptamethyl-6-oxo-2,3,4a,5,7,8,9,10,12,12a,13,14-dodecahydro-1h-picen-3-yl benzoate

C39H54O5 (602.3971)

10-{[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H54O5 (602.3971)

(1r,3as,5ar,5br,7ar,9s,11ar,11br,13as,13bs)-9-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

C39H54O5 (602.3971)

9-{[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

C39H54O5 (602.3971)

(1r,3as,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-9-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

C39H54O5 (602.3971)

26-hydroxy-28-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octacosan-2-one

C34H66O8 (602.4757)

(3s,4ar,6ar,6bs,8as,12as,14ar,14br)-8a-formyl-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H54O5 (602.3971)

3-cis-p-coumaroyl maslinic acid

C39H54O5 (602.3971)

{"Ingredient_id": "HBIN008394","Ingredient_name": "3-cis-p-coumaroyl maslinic acid ","Alias": "3-cis-p-coumaroyl maslinic acid","Ingredient_formula": "C39H54O5","Ingredient_Smile": "CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C)OC(=O)C=CC6=CC=CC=C6)O)C)C)C2C1)C)C(=O)O)C","Ingredient_weight": "602.8 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "13861;13862","PubChem_id": "16664518","DrugBank_id": "NA"}

3-o-(e)-coumaroyloleanolicacid

C39H54O5 (602.3971)

{"Ingredient_id": "HBIN009320","Ingredient_name": "3-o-(e)-coumaroyloleanolicacid","Alias": "NA","Ingredient_formula": "C39H54O5","Ingredient_Smile": "CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC(=O)C=CC6=CC=C(C=C6)O)C)C)C2C1)C)C(=O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4177","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

3-o-(z)-coumaroyloleanolicacid

C39H54O5 (602.3971)

{"Ingredient_id": "HBIN009445","Ingredient_name": "3-o-(z)-coumaroyloleanolicacid","Alias": "NA","Ingredient_formula": "C39H54O5","Ingredient_Smile": "CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC(=O)C=CC6=CC=C(C=C6)O)C)C)C2C1)C)C(=O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4178","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(3s,5s,6r,3'r,6'r)-5,6-dihydro-5,6-dihydroxy-lutein

C40H58O4 (602.4335)

{"Ingredient_id": "HBIN009669","Ingredient_name": "(3s,5s,6r,3'r,6'r)-5,6-dihydro-5,6-dihydroxy-lutein","Alias": "NA","Ingredient_formula": "C40H58O4","Ingredient_Smile": "CC1=CC(CC(C1C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC2(C(CC(CC2(C)O)O)(C)C)O)C)C)(C)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5593","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

3-trans-p-coumaroyl maslinic acid

C39H54O5 (602.3971)

{"Ingredient_id": "HBIN009750","Ingredient_name": "3-trans-p-coumaroyl maslinic acid ","Alias": "3-trans-p-coumaroyl maslinic acid","Ingredient_formula": "C39H54O5","Ingredient_Smile": "CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C)OC(=O)C=CC6=CC=CC=C6)O)C)C)C2C1)C)C(=O)O)C","Ingredient_weight": "602.8 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "13867;13868","PubChem_id": "16664517","DrugBank_id": "NA"}

α-l-rhamnopyranosyl-3β-hydroxy-lup-20(29)-en-28-oicacid

C36H58O7 (602.4182)

{"Ingredient_id": "HBIN015595","Ingredient_name": "\u03b1-l-rhamnopyranosyl-3\u03b2-hydroxy-lup-20(29)-en-28-oicacid","Alias": "NA","Ingredient_formula": "C36H58O7","Ingredient_Smile": "CC1C(C(C(C(O1)OC2CCC3(C4CCC5C6C(CCC6(CCC5(C4(CCC3C2(C)C)C)C)C(=O)O)C(=C)C)C)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "18713","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(1r,2r,4r)-1-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-18-[(4s)-4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-2,6,6-trimethylcyclohexane-1,2,4-triol

C40H58O4 (602.4335)

(1s,2r,3'ar,3'br,4r,5'ar,7'r,9'ar,9'br,11'r,11'ar)-7'-(acetyloxy)-4-(2-ethoxypropan-2-yl)-1,3'a,3'b,6',6',9'a-hexamethyl-dodecahydro-3,7-dioxaspiro[bicyclo[2.2.1]heptane-2,1'-cyclopenta[a]phenanthren]-11'-yl acetate

C36H58O7 (602.4182)

4-hydroxy-3a,5a,5b,8,8,11a,13b-heptamethyl-1-(prop-1-en-2-yl)-tetradecahydro-1h-cyclopenta[a]chrysen-9-yl 3-(4-hydroxyphenyl)prop-2-enoate

C40H58O4 (602.4335)

(1r,3as,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-9-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

C36H58O7 (602.4182)

31-hydroxy-2-methoxy-2,6,10,14,19,23,27,31-octamethyldotriaconta-6,8,10,12,14,16,18,20,22,26-decaen-5-one

C41H62O3 (602.4699)

27-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octacosan-3-one

C34H66O8 (602.4757)

(1s,2s,6s,10s,11r,13s,15r)-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-13-yl pentadecyl carbonate

C36H58O7 (602.4182)

(1r,3ar,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2z)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C40H58O4 (602.4335)

2,2,4a,6a,6b,9,9,12a-octamethyl-10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4,5,6,7,8,8a,10,11,12,12b,14b-dodecahydro-1h-picen-13-one

C36H58O7 (602.4182)

(1r,3as,5ar,5br,7ar,9r,11ar,11br,13ar,13br)-9-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

C39H54O5 (602.3971)

(1r,2r,4s)-1-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-18-[(4r)-4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-2,6,6-trimethylcyclohexane-1,2,4-triol

C40H58O4 (602.4335)

6-[(9e,11e,13e,15e)-18-(2,4-dihydroxy-2,6,6-trimethylcyclohexylidene)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-1,5,5-trimethylcyclohexane-1,3-diol

C40H58O4 (602.4335)

1-[(1e,3e,5e,7e,9e)-18-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-2,6,6-trimethylcyclohexane-1,2,4-triol

C40H58O4 (602.4335)

(1r,3as,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-9-{[(2z)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

C39H54O5 (602.3971)

11-[(acetyloxy)methyl]-4,4,6b,8a,11,12b,14b-heptamethyl-6-oxo-2,3,4a,5,7,8,9,10,12,12a,13,14-dodecahydro-1h-picen-3-yl benzoate

C39H54O5 (602.3971)

3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C40H58O4 (602.4335)

(3r,6s,8r,11s,12s,16r)-7,7,12,16-tetramethyl-15-(6-methylhept-5-en-2-yl)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C40H58O4 (602.4335)

2-[(2s,5s)-5-[(1s,3ar,3br,5ar,7s,9ar,9br,11r,11ar)-7,11-bis(acetyloxy)-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl]-5-methyloxolan-2-yl]propan-2-yl acetate

C36H58O7 (602.4182)

10-{[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-2,4a,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-2-carboxylic acid

C39H54O5 (602.3971)

(3r,4ar,6ar,8ar,12ar,12bs,14ar,14br)-4,4,6a,8a,11,11,12b,14b-octamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C40H58O4 (602.4335)

(3s,4ar,6ar,8ar,12ar,12bs,14ar,14br)-4,4,6a,8a,11,11,12b,14b-octamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C40H58O4 (602.4335)

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,5as,7s,9ar,11ar)-3a,6,6,9a,11a-pentamethyl-1-[(2r)-6-methyl-5-methylideneheptan-2-yl]-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C37H62O6 (602.4546)

4,12,20,24,26,28-hexahydroxytritriacontane-2,10,18-trione

C33H62O9 (602.4394)

(3s,4ar,6ar,8ar,12ar,12bs,14ar,14bs)-4,4,6a,8a,11,11,12b,14b-octamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-yl (2z)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C40H58O4 (602.4335)

2-[(2e,4e,6e,8e,10e,12e)-17-{4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl}-6,11,15-trimethylheptadeca-2,4,6,8,10,12,14-heptaen-2-yl]-4,4,7a-trimethyl-2,5,6,7-tetrahydro-1-benzofuran-6-ol

C40H58O4 (602.4335)

(1s,2s,4s)-1-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-18-[(4r)-4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-2,6,6-trimethylcyclohexane-1,2,4-triol

C40H58O4 (602.4335)

(4as,6ar,6br,8ar,10s,12ar,12br,14bs)-10-hydroxy-6a-[(3z)-4-(4-hydroxyphenyl)-2-oxobut-3-en-1-yl]-2,2,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H54O5 (602.3971)

(2s,3s,4s,5r,6r)-6-{[(1r,3as,3br,7s,9ar,9bs,11ar)-3a,6,6,9a,11a-pentamethyl-1-[(2r)-6-methylhept-5-en-2-yl]-1h,2h,3h,3bh,4h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C36H58O7 (602.4182)

(4as,6as,6br,8ar,10s,12ar,12br,14bs)-2,2,6a,6b,9,9,12a-heptamethyl-10-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C36H58O7 (602.4182)

(4e,8e)-3,7-dihydroxy-2,4,6,8,10,12,14,16-octamethyl-11-{[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadeca-4,8-dienoic acid

C32H58O10 (602.403)

(1s,2r,4as,6ar,6br,8ar,10s,12ar,12br,14bs)-10-hydroxy-6a-[(3e)-4-(4-hydroxyphenyl)-2-oxobut-3-en-1-yl]-1,2,6b,9,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C39H54O5 (602.3971)

(4as,6as,6br,8ar,10r,11r,12ar,12br,14bs)-11-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-10-{[(2z)-3-phenylprop-2-enoyl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H54O5 (602.3971)

(1r,3as,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-9-{[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

C39H54O5 (602.3971)

4,4,6a,6b,8a,11,11,14b-octamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl 3-(3,5-dihydroxyphenyl)prop-2-enoate

C39H54O5 (602.3971)

(4ar,6as,6br,8ar,10s,12as,12br,14br)-2,2,4a,6a,6b,9,9,12a-octamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4,5,6,7,8,8a,10,11,12,12b,14b-dodecahydro-1h-picen-13-one

C36H58O7 (602.4182)

(3r,4ar,6ar,8ar,12ar,12bs,14ar,14br)-4,4,6a,8a,11,11,12b,14b-octamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-yl (2z)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C40H58O4 (602.4335)

(1s,3as,4s,5ar,5br,7ar,9s,11ar,11br,13as,13br)-4-hydroxy-3a,5a,5b,8,8,11a,13b-heptamethyl-1-(prop-1-en-2-yl)-tetradecahydro-1h-cyclopenta[a]chrysen-9-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C40H58O4 (602.4335)

8a-formyl-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H54O5 (602.3971)

5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-9-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

C36H58O7 (602.4182)

(4as,6as,6br,8ar,10s,12ar,12br,14bs)-10-{[(2z)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H54O5 (602.3971)

2-{[3a,6,6,9a,11a-pentamethyl-1-(6-methyl-5-methylideneheptan-2-yl)-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C37H62O6 (602.4546)

(6e,8e,10e,12e,14e,16e,18e,20e,22e,26e)-31-hydroxy-2-methoxy-2,6,10,14,19,23,27,31-octamethyldotriaconta-6,8,10,12,14,16,18,20,22,26-decaen-5-one

C41H62O3 (602.4699)

(3ar,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2e)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoate

C40H58O4 (602.4335)

(3s,4ar,6ar,6bs,8ar,12ar,14ar,14bs)-4,4,6a,6b,8a,11,11,14b-octamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl (2e)-3-(3,5-dihydroxyphenyl)prop-2-enoate

C39H54O5 (602.3971)

(4as,6as,6br,8ar,10r,11r,12ar,12br,14bs)-11-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-10-{[(2e)-3-phenylprop-2-enoyl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H54O5 (602.3971)

(26r)-26-hydroxy-28-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octacosan-2-one

C34H66O8 (602.4757)

(3s,4ar,6ar,6bs,8ar,12ar,14ar,14br)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C40H58O4 (602.4335)

3a-formyl-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H54O5 (602.3971)

(1s,2r,4s)-1-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-18-[(4r)-4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-2,6,6-trimethylcyclohexane-1,2,4-triol

C40H58O4 (602.4335)

3-[(5-aminopentyl)(hydroxy)carbamoyl]-n-[5-(n-hydroxy-3-{[5-(n-hydroxy-3-methylbutanamido)pentyl]-c-hydroxycarbonimidoyl}propanamido)pentyl]propanimidic acid

C28H54N6O8 (602.4003)

(1s,2r,3r,5r,7s,10s,11r,14r,15s)-15-[(2r,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3-hydroxy-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbut-2-enoate

C36H58O7 (602.4182)

(4as,6as,6br,8ar,10s,12ar,12br,14br)-10-{[(2z)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H54O5 (602.3971)

4,4,6a,8a,11,11,12b,14b-octamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-yl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C40H58O4 (602.4335)

10-{[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C39H54O5 (602.3971)

2,2,6a,6b,9,9,12a-heptamethyl-10-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C36H58O7 (602.4182)

4,6,8,10,12,14,16,18-octamethoxy-19-methylpentacosa-1,19-diene

C34H66O8 (602.4757)

3-[(3s,3as,5ar,6s,7r,9r,9ar)-9-{[(2r,3r)-2-hydroxy-3-methylpentanoyl]oxy}-7-(2-hydroxypropan-2-yl)-3a,6,9a-trimethyl-3-[(3s,5s)-5-(2-methylprop-1-en-1-yl)oxolan-3-yl]-2h,3h,4h,5h,5ah,7h,8h,9h-cyclopenta[a]naphthalen-6-yl]propanoic acid

C36H58O7 (602.4182)

(1r,3ar,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C40H58O4 (602.4335)

(2s,4as,6as,6br,8ar,10r,12ar,12br,14br)-10-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-2,4a,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-2-carboxylic acid

C39H54O5 (602.3971)

3,7-dihydroxy-2,4,6,8,10,12,14,16-octamethyl-11-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}octadeca-4,8-dienoic acid

C32H58O10 (602.403)

(2s,6s,7ar)-2-[(2e,4e,6e,8e,10e,12e,14e)-17-[(1s,4s,6r)-4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl]-6,11,15-trimethylheptadeca-2,4,6,8,10,12,14-heptaen-2-yl]-4,4,7a-trimethyl-2,5,6,7-tetrahydro-1-benzofuran-6-ol

C40H58O4 (602.4335)

6-{[3a,6,6,9a,11a-pentamethyl-1-(6-methylhept-5-en-2-yl)-1h,2h,3h,3bh,4h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C36H58O7 (602.4182)

(4as,6ar,6br,8ar,10s,12ar,12br,14bs)-10-hydroxy-6a-[4-(4-hydroxyphenyl)-2-oxobut-3-en-1-yl]-2,2,6b,9,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H54O5 (602.3971)

(1r,3as,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-3a-formyl-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H54O5 (602.3971)

(4as,6as,6br,8ar,10s,12ar,12br,14bs)-10-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H54O5 (602.3971)

7-hydroxy-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl 3-(4-methoxyphenyl)prop-2-enoate

C40H58O4 (602.4335)

(3s,4ar,6ar,6bs,7s,8ar,12as,14ar,14br)-7-hydroxy-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl (2e)-3-(4-methoxyphenyl)prop-2-enoate

C40H58O4 (602.4335)

(4as,6as,6br,8as,10s,12as,12br,14bs)-10-[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H54O5 (602.3971)

(1r,3s)-6-[(3e,5e,7e,9e,11e,13e,15e,17e)-18-[(1r,2r,4s)-2,4-dihydroxy-2,6,6-trimethylcyclohexyl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-ylidene]-1,5,5-trimethylcyclohexane-1,3-diol

C40H58O4 (602.4335)

15-[5-(1,2-dihydroxy-2-methylpropyl)-2-methoxyoxolan-3-yl]-3-hydroxy-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbut-2-enoate

C36H58O7 (602.4182)

(4as,6as,6br,8ar,10s,12ar,12br,14br)-10-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H54O5 (602.3971)

(1s,2r,4as,6ar,6br,8ar,10s,12ar,12br,14bs)-10-hydroxy-6a-[4-(4-hydroxyphenyl)-2-oxobut-3-en-1-yl]-1,2,6b,9,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C39H54O5 (602.3971)

(1r,3as,5ar,5br,7ar,9s,11as,11br,13ar,13bs)-3a-formyl-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H54O5 (602.3971)

7-(2-hydroxypropan-2-yl)-6-(3-methoxy-3-oxopropyl)-3a,6,9a-trimethyl-3-[5-(2-methylprop-1-en-1-yl)oxolan-3-yl]-2h,3h,4h,5h,5ah,7h,8h,9h-cyclopenta[a]naphthalen-9-yl 2-hydroxy-3-methylbutanoate

C36H58O7 (602.4182)

(1s,2r,4as,6ar,6br,8ar,10s,12ar,12br,14bs)-10-hydroxy-6a-[(3z)-4-(4-hydroxyphenyl)-2-oxobut-3-en-1-yl]-1,2,6b,9,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C39H54O5 (602.3971)

(3r,4ar,6ar,8ar,12ar,12bs,14ar,14bs)-4,4,6a,8a,11,11,12b,14b-octamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C40H58O4 (602.4335)

4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C40H58O4 (602.4335)

(1s,2r,3r,5r,7r,10s,11r,14r,15s)-15-[(2s,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3-hydroxy-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbut-2-enoate

C36H58O7 (602.4182)

7'-(acetyloxy)-4-(2-ethoxypropan-2-yl)-1,3'a,3'b,6',6',9'a-hexamethyl-dodecahydro-3,7-dioxaspiro[bicyclo[2.2.1]heptane-2,1'-cyclopenta[a]phenanthren]-11'-yl acetate

C36H58O7 (602.4182)

(1s,2r,4as,6as,6br,10s,12ar)-10-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C39H54O5 (602.3971)

(3s,3as,5ar,6r,7r,9r,9ar)-7-(2-hydroxypropan-2-yl)-6-(3-methoxy-3-oxopropyl)-3a,6,9a-trimethyl-3-[(3s,5s)-5-(2-methylprop-1-en-1-yl)oxolan-3-yl]-2h,3h,4h,5h,5ah,7h,8h,9h-cyclopenta[a]naphthalen-9-yl (2r)-2-hydroxy-3-methylbutanoate

C36H58O7 (602.4182)

10-[3-(3,4-dihydroxyphenyl)prop-2-enoyl]-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H54O5 (602.3971)

(4as,6as,6br,8ar,10r,11r,12ar,12br,14bs)-11-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-10-[(3-phenylprop-2-enoyl)oxy]-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C39H54O5 (602.3971)

(3s,4ar,6ar,8ar,12ar,12bs,14ar,14bs)-4,4,6a,8a,11,11,12b,14b-octamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C40H58O4 (602.4335)

(1s,2r,3r,5r,7r,10s,11r,14r,15s)-15-[(2r,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3-hydroxy-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbut-2-enoate

C36H58O7 (602.4182)

(4r,12r,20r,24s,26r,28r)-4,12,20,24,26,28-hexahydroxytritriacontane-2,10,18-trione

C33H62O9 (602.4394)

(3r,4ar,6ar,8ar,12ar,12bs,14ar,14br)-4,4,6a,8a,11,11,12b,14b-octamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-yl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C40H58O4 (602.4335)